Shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Rating) fell 12.9% during trading on Thursday following insider selling activity. The company traded as low as $89.02 and last traded at $89.03. 309,595 shares traded hands during mid-day trading, a decline of 73% from the average session volume of 1,151,394 shares. The stock had previously closed […]
First Light Asset Management LLC boosted its position in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Rating) by 95.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 2,062,453 shares of the company’s stock after acquiring an additional 1,007,468 shares during the quarter. Reata Pharmaceuticals accounts for 7.3% of First Light Asset Management […]
SVB Leerink upgraded shares of Reata Pharmaceuticals (NASDAQ:RETA – Get Rating) from a market perform rating to an outperform rating in a research note issued to investors on Monday, PriceTargets.com reports. Several other research analysts have also issued reports on RETA. SVB Securities raised Reata Pharmaceuticals from a market perform rating to an outperform rating […]
Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Rating) SVP Andrea Loewen sold 6,750 shares of the business’s stock in a transaction dated Friday, May 12th. The shares were sold at an average price of $86.26, for a total transaction of $582,255.00. Following the transaction, the senior vice president now directly owns 32,007 shares in the company, […]
Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Rating) CFO Manmeet Singh Soni sold 21,507 shares of the firm’s stock in a transaction on Monday, May 15th. The shares were sold at an average price of $84.56, for a total transaction of $1,818,631.92. Following the sale, the chief financial officer now owns 116,797 shares in the company, […]